SBI Healthcare Opportunities Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1383 Cr | ₹3416 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 28 Sep 2023 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.17 | 1.95 |
| Manager | Dhruv Muchhal | Pradeep Kesavan |
| ISIN Code | INF179KC1HL7 | INF200K01446 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | 3.72% | 2.92% |
| 6 Month | 24.41% | 18.22% |
| 1 Year | 51.26% | 43% |
| 3 Year | - | 24.89% |
| 5 Year | - | 29.13% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 45.69% | 35.46% |
| 3 Year | - | 34.45% |
| 5 Year | - | 27.66% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 62.28% | 14.51% |
| 3 Year | - | 17.07% |
| 5 Year | - | 12.42% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | - | 14.02% |
| Sharp | - | 0.78% |
| Beta | - | 0.87% |
| Alpha | - | 3.06% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Dhruv Muchhal | Pradeep Kesavan |
| Total AUM | ₹520687 Cr | ₹434274 Cr |
| Fund Manage | 40 | 43 |
| HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.98 | 7.82 |
| Small Cap | 33.12 | 37.28 |
| Large Cap | 32.5 | 30.06 |
| Mid Cap | 32.4 | 24.84 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.98 | 7.82 |
| Pharmaceuticals & Biotechnology | 74.71 | 57.84 |
| Healthcare Services | 22.28 | 25.46 |
| Retailing | 1.03 | - |
| Chemicals & Petrochemicals | - | 3.5 |
| Healthcare Equipment & Supplies | - | 5.38 |
Top Comparisons
HDFC Balanced Advantage Fund - Growth Plan
3Y Returns22.12%
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns12.03%
Mahindra Manulife Ultra Short Duration Fund - Regular Plan - Growth
3Y Returns6.13%
INVESCO INDIA ULTRA SHORT DURATION FUND - Growth
3Y Returns6%
Kotak Small Cap Fund - Growth
3Y Returns18.42%
Quant Small Cap Fund-Growth
3Y Returns26.12%
Kotak Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns18.45%
HSBC NIFTY NEXT 50 INDEX FUND - Regular Growth
3Y Returns18.03%